Comparison of hypotensive effect and prevention to progression of diabetic nephrolopathy with Olmesartan and Ca channel blocker in patient of type 2 diabetic
Not Applicable
- Conditions
- hypertension with type 2 diabetis
- Registration Number
- JPRN-UMIN000004253
- Lead Sponsor
- Endcrinology and Diabetis,Saitama Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
patient of 1)RAS inhibitor with Ca channel Blocker 2)except from 20 to 80 years old 3)SBP less than 130mmHg or DBP less than 80mmHg 4)HbA1c over 8.0% 5)S-Cr over 2.5mg/dL 6)hypersensitivity to drug in object 7)inadequate with Doctor's decision
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Office blood pressure , Albumin-Creatinin Ratio , Serum-Creatinin Consentration
- Secondary Outcome Measures
Name Time Method